Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

150.73 -1.65 (-1.08%)
Official Closing Price Updated: 6:30 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
7 Value Stocks to Buy and Hold for a Decade of Dominance
Discover the enduring value of seven key value stocks to buy and hold in diverse sectors, presenting unparalleled opportunities. 
Via InvestorPlace
3 Cheap Healthcare Stocks to Buy Now: May 2024
Healthcare is cheaper than the market and has secular growth tailwinds, meaning these cheap healthcare stocks have upside. 
Via InvestorPlace
3 Robotics and Automation Stocks to Sell in May Before They Crash & Burn
Discover three robotics and automation stocks that face significant challenges, including market saturation and competitive pressures. 
Via InvestorPlace
Why NYSE:JNJ is a Top Pick for Dividend Investors.
Is JOHNSON & JOHNSON (NYSE:JNJ) a Good Fit for Dividend Investing? 
Via Chartmill
Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market
The market often doesn't know what to make of them at first, giving savvy investors first crack at these stock spinoffs to buy. 
Via InvestorPlace
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases. 
Via Benzinga
1 Passive Income Vehicle Every Investor Should Own
This healthcare giant is a rock-solid passive income play. 
Via The Motley Fool
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,... 
Via Benzinga
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
From Johnson & Johnson
Via Business Wire
Consumer Staples Standouts: 3 Defensive Gems to Safeguard Your Portfolio
These top consumer staples giants could be among the best ways for investors to retain defensive exposure in this current market. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
1 No-Brainer Growth Stock to Buy and Hold for 10 Years
This company's potential far outweighs its risks. 
Via The Motley Fool
Best Foundational Stocks
Building the foundation of investors portfolio with the best US foundational stocks by sector. 
Via Talk Markets
J&J: A Healthy Dose Of Income And Growth
Johnson & Johnson (JNJ)— founded in 1886 — is a diversified healthcare company and a leader in the area of innovative medicine and medical devices. 
Via Talk Markets
Johnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use
Johnson & Johnson's Megadyne Mega Soft Pediatric Patient Return Electrodes recalled due to patient burns. FDA's Class I recall impacts 21,200 devices. 
Via Benzinga
Exposures Product Safety
Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock
Kenvue stock is up on Monday after Johnson & Johnson announced plans to sell its entire stake in KVUE following last year's spinoff. 
Via InvestorPlace
2 Supercharged Dividend Stocks to Buy and Hold for Years
Consistent passive income is one top goal long-term investors should have for their portfolio. 
Via The Motley Fool
The 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024
Load up on the most undervalued stocks with strong fundamentals for steady growth and passive income over the years. 
Via InvestorPlace
7 Reliable Dividend Stocks to Keep Your Portfolio Upright
Although the idea of reliable dividend stocks isn’t the most exciting concept, these enterprises can help you sleep easy at night. 
Via InvestorPlace
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Johnson & Johnson isn't the ultra-safe stock it used to be. 
Via The Motley Fool
The 3 Best Mutual Funds to Buy in May 2024
Consider the best mutual funds to buy for high returns and low fees. They each have unique strategies meant to maximize returns on capital. 
Via InvestorPlace
The 3 Most Undervalued Stocks to Buy in May 2024
If you're thinking of sitting out the summer, here are three undervalued stocks to buy in May that will protect you from downside tech risk. 
Via InvestorPlace
3 Biotech Stocks to Sell in May Before They Crash & Burn
Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio. 
Via InvestorPlace
Prediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From Now
Three time-tested businesses have the necessary catalysts to blow past electric-vehicle (EV) maker Tesla by 2026. 
Via The Motley Fool
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. 
Via InvestorPlace
What Is the Dividend Payout for Johnson & Johnson Stock?
Here's a closer look at the healthcare behemoth's dividend. 
Via The Motley Fool
The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024
These undervalued S&P 500 stocks are legacy names with strong fundamentals and a global presence. Buy them on the dip. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024
Johnson & Johnson, PepsiCo, and Southern Company are three reliable dividend stocks providing consistent growth and attractive yields in 2024. 
Via InvestorPlace
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.